/Investor DB

Canaan Partners

Venture capitaloperating company · company profile

Stamford · Pre-Seed–Series A · 31 people tracked

Also known as Abyrx, Canaan Partners · Canaan · CANAAN MANAGEMENT, LLC · Canaan Natural Gas Management, Llc

Find your way into Canaan Partners

Sign up to see every warm intro you have to Canaan Partners

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Canaan Partners team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

Canaan emphasizes a personal, non-formulaic approach to venture investing, drawing on values built over three decades. The firm prizes high performance with low ego, favoring understated and effective partners over self-promotion. It values a diverse team whose varied backgrounds inform a collective approach spanning industries, generations, and geographies. Canaan positions the full team's network and operational resources behind each portfolio company, helping with recruiting, go-to-market, and strategic pivots. The firm treats founders with respect, transparency, and honesty, viewing portfolio companies like family and tying its own success to theirs. It aims to stay closely informed and add value while knowing when to step back and let founders lead.

Source: firm website, verified Sep 29, 2026.

Stage
Pre-Seed–Series A
Check
$500K – $20M
HQ
Stamford, Connecticut, US
Leads rounds
Leads
Instruments
Equity
Founded
1987
Last 12 months
19 investments
AUM
$7B
VC funds
29
Tracked investments
501
Unicorns
12
IPOs
21
Acquisitions
105

Team · 31 people

from the firm's website & curated & public directories
Brenton Ahrens· General Partner
Derek Wu· Associate / East Coastin

12 people who came through Canaan Partners went on to found or lead other companies.

What they invest in

from 297 of 501 portfolio companies

AI & Machine Learning ×86Biotech ×74SaaS ×72Healthtech ×68Enterprise Software ×60Fintech ×44Consumer ×34Medical Devices ×34

HQs:United States×227United Kingdom×12Canada×4Germany×4Nigeria×3Belgium×2

Who they back

founder profiles across 167 portfolio companies
32%
solo founders
53 of 167 mapped founding teams
37%
repeat founders
of 177 founders with career history
~3 yrs
old at investment
median across 106 dated deals

Founding team size:solo founder×532 founders×683 founders×204+ founders×26

Where their founders studiedfrom 160 founders with education data

University of California, Berkeley ×9Princeton University ×6Stanford University Graduate School of Business ×6University of Illinois Urbana-Champaign ×6Cornell ×5Stanford University ×5Columbia University ×4Harvard Business School ×4

What their founders studiedfrom 165 founders with field-of-study data

Computer Science ×48Engineering ×43Business & Management ×32Economics ×17Finance & Accounting ×15Life Sciences ×8Mathematics & Statistics ×7Medicine ×7

Where their founders worked beforefrom 177 founders with career history

Microsoft ×9Apple ×7Stanford University ×6AOL ×4Meta ×4Uber ×4Carnegie Mellon University ×3Cisco ×3

Accelerator rootsportfolio companies that came through a program

Y Combinator ×10Techstars ×3

28 founders hold a PhD · 31 hold an MBA (of 173 with degree data)

Investments · 501 tracked

founders shown can be your intro path

By year:2026 · 142025 · 222024 · 162023 · 102022 · 102021 · 272020 · 172019 · 132018 · 172017 · 132016 · 112015 · 25237 dated

Arvinas Holding Co. LLCarvinas.comin𝕏NASDAQ: ARVNSeries A · Oct 2015 · $15M

Arvinas is a biopharmaceutical company developing PROTAC protein degrader therapies, with a pipeline focused on oncology and neurology.

BiotechHealthtechNew Haven, US

Sean Cassidy(Executive Officer)inManuel Litchman(Executive Officer, Director)inRandy Teel(President and Chief Executive Officer; Director)inCraig Crews(Founder)

BoardStephen Squinto(Director)inLiam Ratcliffe(Director)in

Board seatTimothy Shannon· per SEC Form D

Co-investors5AM VenturesAccess BiotechnologyConnecticut InnovationsNextech InvestRA CapitalSolasta Ventures+2 more

Cardlyticscardlytics.comin𝕏NASDAQ: CDLXMay 2017

Cardlytics operates a commerce media platform that uses card-linked purchase data to deliver targeted offers and closed-loop measurement for marketers and advertisers, and personalized rewards programs for banks and publishers.

AdTechFintechMarketing TechAtlanta, US

Scott Grimes(Founder)inLynne Laube(Founder)inKirk Somers(Executive Officer)inDavid Evans(Executive Officer)inAmit Gupta(Chief Executive Officer and Director)in

BoardJohn Klinck(Director)in

Board seatJohn Balen· per SEC Form D

Co-investorsBaroda VenturesKinetic Ventures, L.L.C.Next Coast VenturesSavano Capital PartnersDiscovery CapitalHyperplane Venture Capital+2 more

CytomX Therapeuticscytomx.comin𝕏NASDAQ: CTMXDec 2014

CytomX is a clinical-stage biopharmaceutical company developing conditionally activated biologic cancer therapies, including antibody-based treatments designed to target tumors while limiting effects on healthy tissue.

BiotechHealthtechSouth San Francisco, US

Sean A. McCarthy(Chief Executive Officer and Chairman)inMarcia P. Belvin(SVP, Chief Scientific Officer)inDawn Benson(SVP, Quality and Product Manufacturing)inWayne Chu(Chief Medical Officer)Rachael Lester(SVP, Chief Business Officer)inChris Ogden(Chief Financial Officer)in

Board seatTimothy Shannon· per SEC Form D

Co-investorsATEL VenturesLongitude CapitalPfizer Venture InvestmentsWellington ManagementOrbiMedThird Rock Ventures

Liquidia Corporationliquidia.cominNASDAQ: LQDAApr 2021

Liquidia develops and commercializes inhaled and injectable therapies for pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease.

BiotechMorrisville, US

Damian deGoa(Executive Officer, Director)inMichael Kaseta(Executive Officer)in

BoardPaul B. Manning(Director)inJoanna Horobin(Director)Raman Singh(Director)

Board seatStephen Bloch· per SEC Form D

Co-investorsNew Enterprise Associates (NEA)Xeraya CapitalPBM Capital

Liquidia TechnologiesNASDAQ: LQDASeries C · Feb 2018 · $20M

Liquidia Technologies is a biopharmaceutical company that develops and commercializes drugs for pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease, including YUTREPIA, an inhaled dry-powder treprostinil formulation, and treprostinil injection through a profit-sharing arrangement with Sandoz, along with pipeline candidates based on its PRINT particle-engineering platform.

BiotechMorrisville, US

Kevin Gordon(President and Chief Financial Officer)Robert Lippe(Chief Operations Officer)Benjamin Maynor(Senior Vice President, Research and Development)Timothy Albury(Executive Officer)Neal F. Fowler(Chief Executive Officer)Roger A. Jeffs(Chief Executive Officer)in

Board seatStephen Bloch· per SEC Form D

Co-investorsPappas Capital

NextCurenextcure.comNASDAQ: NXTCSeries A · Dec 2015 · $67M

Nextcure is a clinical-stage biopharmaceutical company developing immunotherapies targeting IO pathways, with a focus on oncology applications.

BiotechBeltsville, US

Michael Richman(Executive Officer, Director)Timothy Mayer(Executive Officer)inUdayan Guha(Executive Officer)inSteven P. Cobourn(Executive Officer)inSourav Kundu(Executive Officer)inKevin Shaw(Executive Officer)in

Board seatTimothy Shannon· per SEC Form D

Co-investorsBay City CapitalLAVLilly Asia VenturesPfizer Venture InvestmentsQuan CapitalSofinnova Ventures+4 more

Rallybio HoldingsNASDAQ: RLYBMar 2020

Rallybio is a clinical-stage biotechnology company developing therapies for severe and rare diseases, with a lead program in RLYB116, a C5 complement inhibitor in clinical development, and a preclinical program in RLYB332, a matriptase-2 antibody for iron overload disorders.

HealthtechFarmington, US

Jeffrey M. Fryer(Executive Officer, Director)Martin W. Mackay(Executive Officer, Director)Stephen Uden(Executive Officer, Director)

Board seatTimothy Shannon· per SEC Form D

Co-investors5AM VenturesPivotal Life Sciences

TYRA Biosciencestyra.bioinNASDAQ: TYRASeries A · Feb 2024 · $50M

Tyra is developing oral dabogratinib, a small-molecule therapy being evaluated in clinical studies for skeletal dysplasia and urologic cancers.

BiotechHealthtechCarlsbad, US

Todd Harris, Ph.D.(Executive Officer, Director)Hiroomi Tada, M.D., Ph.D.(Executive Officer)Daniel Bensen(Executive Officer)inAlan Fuhrman(Executive Officer)inTodd Harris(President, Chief Executive Officer and Director)inBhavesh Ashar(Chief Operating Officer)in

Board seatNina Kjellson· per SEC Form D

Co-investorsAlta PartnersBioBritNextech InvestRA Capital

Aevaaeva.comin𝕏NASDAQ: AEVASeries A · Jan 2017 · $45M

Aeva develops FMCW-based 4D LiDAR sensors and perception software that measure velocity and range simultaneously, using silicon photonics to put LiDAR elements on a chip.

HardwareMobility & TransportationSemiconductorsPalo Alto, US

SOROUSH SALEHIAN DARDASHTI(Executive Officer, Director)MINA REZK(Executive Officer, Director)inSoroush Salehian(Founder)inMina Rezk(Founder)

BoardSHAHIN FARSHCHI(Director)inYuan Chen(Capital Allocator)in

Co-investors11.2 CapitalLux CapitalNext47Socii CapitalLockheed Martin VenturesPorsche Ventures

Arbearberobotics.comin𝕏NASDAQ: ARBE

Arbe Robotics develops ultra-high-resolution 4D imaging radar for autonomous vehicles and advanced sensing applications.

AI & Machine LearningHardwareRobotics

Kobi Marenko(Founder)Noam Arkind(Founder)Oz Fixman(Founder)

Co-investors360 CapitalCatalyst Investments, L.P.iAngelsiAngels CapitalLoftyInc CapitalManiv Mobility+6 more

Ciscocisco.comin𝕏NASDAQ: CSCO

Cisco Systems designs and sells networking hardware, software, and services—including routers, switches, and cloud-based applications—to enterprise, service provider, and consumer markets globally.

Cloud ComputingCybersecurityEnterprise SoftwareIoTSan Jose, US

Sandra Lerner(Founder)Leonard Bosack(Founder)John ChambersinChuck Robbins(Chair and Chief Executive Officer)inMark Patterson(Chief Financial Officer)inHans Robertson(Founder)

Co-investorsSequoia CapitalVintheraFelicis VenturesForgePoint CapitalHeadlineLightspeed Venture Partners

DexComdexcom.cominNASDAQ: DXCMMay 2016

Dexcom develops continuous glucose monitoring (CGM) systems and glucose biosensors, including the Dexcom G7 and the over-the-counter Stelo biosensor, that send real-time glucose readings to a phone or receiver.

BiotechDigital HealthHealthtechMedical DevicesSan Diego, US

Richard Doubleday(Executive Officer)Steven R. Pacelli(Executive Officer)inJeffrey Moy(Executive Officer)Terrance H. Gregg(Executive Officer, Director)Jorge Valdes(Executive Officer)inJohn D. Lister(Executive Officer)in

Co-investorsBlack Diamond Ventures

Ginkgo Bioworksginkgo.bioin𝕏NYSE: DNAJul 2014

Ginkgo Bioworks builds autonomous labs that accelerate bioengineering for applications in pharmaceutical, agricultural, and industrial biotechnology.

AgTechAI & Machine LearningBiotechDeep TechHealthtechRoboticsBoston, US

Jason Kelly(Founder)inReshma Shetty(Founder)inBarry Canton(Founder)inAustin Che(Founder)inTom Knight(Founder)inBartholomew Canton(Executive Officer)

Co-investors11.2 CapitalAllen Institute for AI (AI2) IncubatorAzure Capital PartnersB3 HoldingBlue Owl CapitalCannage Capital+62 more

Ideaya Biosciencesideayabio.comin𝕏NASDAQ: IDYA

IDEAYA is a precision medicine oncology company developing first-in-class targeted therapies and rational drug combinations for molecularly defined, hard-to-treat cancers.

BiotechDigital HealthHealthtechMedical DevicesSouth San Francisco, US

Paul Stone(Executive Officer)inYujiro S. Hata(President, Chief Executive Officer and Director)

BoardTimothy Shannon(Director)inJohn Diekman(Director)inTerry Rosen(Director)Jeffrey Stein(Director)

Co-investors5AM VenturesGV (Google Ventures)Nextech InvestBiotechnology Value FundWuXi Healthcare Ventures

Instacartinstacart.comin𝕏NASDAQ: CART

Instacart operates a marketplace connecting grocery retailers with customers who order food and household items for same-day delivery or in-store pickup, serving millions of households across North America through partnerships with over 350 retailers.

ConsumerE-commerceFoodTechSan Francisco, US

Apoorva Mehta(Chairman \u0026 Founding CEO)inBrandon Leonardo(Founder)inMax Mullen(Founder)inChris Rogers(Chief Executive Officer)inEmily Reuter(Chief Financial Officer)inHetong Li(Senior Software Engineer)

Co-investorsA*Andreessen HorowitzAvenue Growth PartnersBACKGROUND CAPITALBling CapitalBright Pixel Capital+54 more

Lightspeedlightspeedhq.comin𝕏NYSE: LSPD

Lightspeed provides a point-of-sale and payments platform that lets retail and hospitality businesses sell in person, online, and on social channels from one connected system.

FintechRetail TechSaaSMontreal, GB

Dax Dasilva(Founder)inSarah Bettencourt(Executive Officer)inAsha Bakshani(Executive Officer)inJean Paul Chauvet(Mr. Chauvet is the President of the Issuer.)Lory Ajamian(Executive Officer)inDaniel Micak(Executive Officer)in

Co-investorsAccelConexus Venture CapitalEntrée CapitalInovia CapitalRachel Zoe VenturesEndeit Capital+4 more

LiveRampliveramp.cominNYSE: RAMPacquired by Acxiom · May 2026 · $2.2B

LiveRamp Ventures is the investment arm of LiveRamp, backing startups building in AI-driven marketing, data collaboration standards, customer personalization, premium internet advertising, programmatic efficiency, and identity resolution.

AdTechData & InfrastructureMarketing TechSan Francisco, US

Travis May(Founder)inScott Howe(CEO)inAuren Hoffman(Founder)

Co-investorsAccelerator VenturesDace VenturesDnx VenturesFelicis VenturesLG Technology VenturesLightspeed Venture Partners+7 more

Matchmatch.comNASDAQ: MTCH

Gary Kremen(Founder)inSpencer Rascoff(Chief Executive Officer)inSteven Bailey(Chief Financial Officer)Sean Edgett(Chief Legal Officer and Secretary)Hesam Hosseini(Chief Operating Officer)Peng T. Ong(Founder)

Protagonist Therapeuticsprotagonist-inc.comin𝕏NASDAQ: PTGXSeries C · Jul 2015 · $40M

Protagonist is a company that emphasizes a diverse and inclusive corporate culture as central to its innovation, with stated goals of creating wins for its organization and for patients.

BiotechHealthtechMilpitas, US

Dinesh V. Patel, PhD(Executive Officer, Director)Dinesh Patel(President & Chief Executive Officer)

BoardAsish K. Xavier, Ph.D.(Director)Michael Panaccio, Ph.D.(Director)Armen Shanafelt, Ph.D.(Director)Paul F. Truex(Director)

Co-investorsAisling CapitalJJDCJohnson & Johnson Innovation – JJDCLilly VenturesRA CapitalStarfish Ventures

Rallybio, LLCrallybio.comin𝕏NASDAQ: RLYBSeries A · Apr 2018 · $37M

Rallybio is a clinical-stage biotech company developing therapies for people with severe and rare diseases, with a pipeline focused on complement dysregulation and hematology.

BiotechHealthtechNew Haven, US

Stephen Uden(Founder)inMartin W. Mackay(Chairman of the Board of Directors)inJon(Chief Financial Officer)

Co-investors5AM VenturesConnecticut InnovationsF-Prime CapitalMitsui Global InvestmentPivotal Life SciencesSolasta Ventures+2 more

Sandforcesandforce.comin𝕏NASDAQ: STX

Seagate manufactures data storage infrastructure, including hard drives and storage systems, for enterprises and organizations managing large-scale data and AI applications.

AI & Machine LearningData & InfrastructureHardware

Alan ShugartDave Mosleyin

Co-investorsAugust CapitalLuminari CapitalOak Investment PartnersStaenberg Venture PartnersStorm VenturesTransLink Capital

Arrakis Therapeuticsarrakistx.comin𝕏Series A · Feb 2017 · $38M✓ verified

Arrakis Therapeutics develops RNA-targeted small-molecule (rSM) medicines, working independently and with partners to create drug candidates aimed at the root causes of disease.

AI & Machine LearningBiotechDeep TechHealthtechCambridge, US

Michael Gilman(Executive Officer, Director)inMark DeLong(CEO)inDavid Neafus(Executive Officer)inRussell C. Petter(Executive Officer)

BoardAlan E. Walts(Director)in

Board seatColleen Cuffaro· per SEC Form D

Co-investorsPfizer VenturesAdvent Life SciencesHBM Healthcare InvestmentsHBM PartnersNextech InvestOUP (Osage University Partners)+2 more

Iantrekiantrekmed.cominOct 2020✓ verified

Iantrek develops micro-interventional ophthalmic surgical technologies focused on enhancing total outflow through the uveoscleral pathway to treat glaucoma.

BiotechHealthtechMedical DevicesElkins Park, US

Tsontcho Ianchulev(Executive Officer, Director)Sean Ianchulev(Founder & Chairman of the Board (CMO))inMichael Haydin(Executive Officer)

BoardJeffry K Weinhuff(Director)Farrell Tyson(Director)

Board seatStephen Bloch· per SEC Form D

Co-investorsaMoonVisionary VenturesCivilization Ventures Management, LlcFemHealth VenturesJSD Capital, LLCUS Venture Partners

Nocion Therapeuticsnociontx.comin𝕏Series A · Dec 2025 · $27M✓ verified

Nocion Therapeutics develops small molecule charged sodium channel blockers (nocions) designed to silence overactive sensory nerves.

BiotechHealthtechMedical DevicesWatertown, US

MATTHEW FRANKEL(Executive Officer)inPETER COUROSSI(Executive Officer)RICHARD BATYCKY(President and Chief Executive Officer)JAMES ELLIS(Executive Officer)MICHAEL LIPP(Executive Officer)inCHRISTOPHER SILBER(Executive Officer)in

Board seatJulie Grant· per SEC Form D

Co-investorsF-Prime CapitalLumira VenturesMission BiocapitalMonograph Capital PartnersOUP (Osage University Partners)

Vivace Therapeuticsvivacetherapeutics.comSeries A · Feb 2025 · $15M✓ verified

Vivace Therapeutics is an oncology-focused drug discovery and development company creating small-molecule inhibitors targeting the Hippo-YAP pathway to treat cancers including mesothelioma, meningioma, and various other tumor types.

BiotechHealthtechMedical DevicesSan Mateo, US

Shuang Qiao(Executive Officer, Director)Sheng Ding(Executive Officer)Sofie Qiao(Founder)

BoardEdward Hu(Director)Jun Wu(Director)Jake Simson(Director)in

Board seatTimothy Shannon· per SEC Form D

Co-investorsRA CapitalCenova CapitalMission Biocapital

Acesion Pharma ApSacesionpharma.cominSeries B · Sep 2023 · $48M✓ verified

Acesion Pharma is a biotech company developing pharmaceutical treatments.

BiotechHealthtechMedical DevicesCopenhagen, DK

Ulrik Sørensen(COO & Co-founder)inMorten Grunnet(CSO & Co-founder)inAnders Gaarsdal Holst(CEO & CMO)inTorgeir Vaage(CFO)in

Co-investorsAlpha Wave GlobalNovo HoldingsBroadview VenturesGlobal BioAccess Fund

AttoTudeattotude.comin✓ verified

AttoTude develops optical interconnect technology for data centers to support artificial intelligence and exascale computing applications.

AI & Machine LearningData & InfrastructureDeep TechHardwareMenlo Park, US

Joy Laskar(AttoTude Founder and CTO)inDave Welch(AttoTude Founder and CEO)in

BoardPeter Wagner(Director)inBasil Alwan(Director)

Co-investorsThe Westly GroupSutter Hill VenturesMayfield FundNosTerra Venture CapitalOpen Field CapitalWing+1 more

Clutchclutch.cain𝕏Series A · Mar 2021 · $16M✓ verified

Clutch is an online platform for buying and selling used cars in Canada, offering pricing, inspection, e-contracting, financing, and delivery through software built in-house.

E-commerceMarketplacesMobility & Transportation

Stephen Seibel(Founder & President)inDan Park(Chief Executive Officer)inAnshul Ruparell(Chief Financial Officer)inRichard Ball(Chief Production Officer)

Co-investorsAltos VenturesFeldsmith CapitalFJ LabsLightspeed Venture PartnersPanache VenturesTrue North Fund+11 more

Curileumcurileum.comin✓ verified

Curileum develops regenerative medicine therapies targeting intestinal stem cells to prevent colorectal cancer.

BiotechHealthtechMedical DevicesLondon, GB

Dr Jeff Moore(Founder & CEO)

Co-investorsAtlas VentureBiotechnology Value FundProspect Venture PartnersOxford Technology Management

Draig Therapeuticsdraigtherapeutics.cominSeries A · Jun 2025 · $140M✓ verified

Draig develops neuropsychiatric therapies targeting glutamate and GABA pathways through AMPA and GABAA receptor modulators, serving patients with neuropsychiatric disorders.

BiotechDeep TechDigital HealthMedical DevicesCardiff, GB

John Atack(Head of Biology & Founder)inSimon Ward(Chief Scientific Officer & Founder)in

Co-investorsAccess BiotechnologySanofi VenturesSV Health InvestorsSR One Capital ManagementBritish Business BankJanus Henderson Investors

ThirtyFiveBio Limitedthirtyfivebio.cominApr 2025✓ verified

ThirtyFiveBio is a drug discovery company developing GPR35 antagonists to treat gastrointestinal diseases, with a focus on ulcerative colitis by targeting epithelial dysfunction.

BiotechDigital HealthHealthtechOxford, GB

James Westcott(CEO)in

Tizona Therapeutics, Inc.tizonatx.com✓ verified

Tizona Therapeutics is a biotechnology company developing first-in-class immuno-oncology therapeutics, including its lead clinical-stage asset TTX-080, aimed at changing cancer progression and relapse.

AI & Machine LearningBiotechHealthtech

Vijay K. Kuchroo(Scientific Co-Founder & Advisory Board Member)Drew Pardoll(Scientific Co-Founder & Advisory Board Member)Dario Vignali(Scientific Co-Founder & Advisory Board Member)Jedd Wolchok(Scientific Co-Founder & Advisory Board Member)Christine O'Brien(Chief Executive Officer & Board Member)inCourtney Beers(Chief Scientific Officer)

Co-investorsMPM BioImpactAbingworthGilead SciencesAstellas Venture Management LLCLightstone Ventures

Trishula Therapeutics, Inc.trishulatx.cominAug 2020✓ verified

Trishula Therapeutics is a clinical-stage biopharmaceutical company developing TTX-030, a first-in-class anti-CD39 antibody for advanced cancers.

BiotechHealthtech

Anil Singhal(President and CEO)inSiddhartha Mitra(Chief Medical Officer)in

Co-investorsMPM BioImpactAstellas Venture Management LLCLightstone Ventures

Aer Therapeuticsaertherapeutics.cominSeries A · Jan 2025 · $36M

Aer Therapeutics develops a science-driven therapeutic aimed at eliminating mucus plugs in the lungs to treat muco-obstructive lung diseases such as COPD and asthma.

BiotechHealthtechMedical DevicesRaleigh, US

Thomas Mathers(Executive Officer, Director)inJames Shaffer(Executive Officer, Director)John Fahy(Director)in

BoardChristy Shaffer(Director)inRishi Gupta(Director)inTim Shannon(Director)in

Board seatTimothy Shannon· per SEC Form D

Co-investorsHatteras Venture PartnersOrbiMedPappas Capital

Agile Stacksagilestacks.comDec 2016

San Mateo, US

Indra Mohan(Director)John Mathon(Executive Officer, Director)

Board seatMaha Ibrahim· per SEC Form D

Co-investorsAlumni VenturesBasecamp FundBlue Ivy VenturesCastor VenturesRosecliff Ventures

AlcherainOct 2021SEC filingmedium confidence

HealthtechWalnut Creek, US

Lester John Lloyd(Previously CEO, now Chairman & Director.)Andrew Thomas Lloyd(General Counsel, Corp Sec'y)Ken Traverso(CEO, Director)Donald Shirley(President, Director)Timothy Patrick Lloyd(CTO, Director)

Board seatWende Hutton· per SEC Form D · filed Nov 2021

Alphina Therapeuticsalphinatx.cominSeries A · Feb 2026 · $40M

Develops therapeutics targeting altered NAD metabolism in cancer, using IP licensed from Yale University.

BiotechNew Haven, US

Barbara Fox(Executive Officer, Director)inNicholas J Galli(Executive Officer, Director)Stanley Choy(Executive Officer)inRanjit Bindra(Director)in

BoardMatthew Cohen(Director)in

Board seatColleen Cuffaro· per SEC Form D

Co-investorsConnecticut InnovationsHighCape CapitalOUP (Osage University Partners)

Antiva Biosciencesantivabio.cominSeries B · May 2015 · $53M

Antiva Biosciences develops a topical therapeutic for women with high-risk HPV infection and pre-cancerous cervical lesions, utilizing antiviral prodrug chemistry.

BiotechFemTechHealthtechMedical DevicesRedwood City, US

Karl Y. Hostetler(Executive Officer, Director)inGail Maderis(Director)inKristine Ball(President & CEO)inElaine Chien(Executive Officer)inSarah Walter(Executive Officer)inRaju Gadiraju(Executive Officer)in

Board seatWende Hutton· per SEC Form D

Co-investorsAdjuvant CapitalAvestria VenturesBrace PharmaGV (Google Ventures)HBM Healthcare InvestmentsHBM Partners+6 more

Apex Aiapex.aiinNov 2018

Apex.AI develops safety-certified, scalable software for mobility systems, including its Apex.OS product (with Apex.Grace runtime SDK and Apex.Ida communication middleware) to help build software-defined vehicles.

AI & Machine LearningDeveloper ToolsMobility & TransportationRoboticsSaaSPalo Alto, US

Jan Becker(Founder)inDejan Pangercic(Founder)in

Board seatRayfe Gaspar-Asaoka· per SEC Form D

Co-investorsInMotion VenturesLightspeed Venture PartnersVolvo Group Venture Capital ABAirbus VenturesToyota VenturesWebb Investment Network

Cargomaticcargomatic.comSeed · Jan 2015 · $3M

Cargomatic operates a marketplace that connects shippers with carriers for local freight, drayage, intermodal, LTL, and full-truckload trucking across the top 20 US ports.

B2B MarketplacesCreator EconomyLogistics & Supply ChainMedia & EntertainmentMobility & TransportationSocialMarina Del Rey, US

Brett Parker(Founder)Jonathan Kessler(Founder)in

Board seatHrach Simonian· per SEC Form D

Co-investorsAcequia Capital (AceCap)Digi VentureseGateway CapitalFJ LabsGreen Meadow VenturesKombo Ventures+15 more

Chrono Therapeuticschronothera.comSeries A · Aug 2016 · $32M

HealthtechHayward, US

GUY DIPIERRO(Director)inALAN LEVY, PH.D.(Executive Officer, Director)ANTHONY RIMAC(Executive Officer)ALAN LEVY(Executive Officer, Director)

BoardELIZABETH ROCKETT(Director)

Board seatWende Hutton· per SEC Form D

Co-investorsCota CapitalEmergent Medical Partners, LLPFountain Healthcare PartnersKaiser Permanente VenturesMission Bay Capital5AM Ventures+2 more

Cidara Therapeuticscidara.comin𝕏Feb 2015SEC filingmedium confidence

Pharmaceutical company developing medicines and vaccines for patient health and treatment.

BiotechHealthtechSan Diego, US

Jeffrey Stein(Executive Officer, Director)Kevin Judice(Director)inKevin Forrest(Executive Officer)Dirk Thye(Executive Officer)inKen Bartizal(Executive Officer)inPaul Daruwala(Executive Officer)in

Board seatNina Kjellson· per SEC Form D · $42M raise · filed Feb 2015

Co-investors5AM VenturesAisling CapitalBain Capital Life SciencesFrazier Life SciencesRA CapitalVivo Capital+1 more

Day One Biopharmaceuticalsdayonebio.comin𝕏Series A · Feb 2021 · $60M

Day One is a biopharmaceutical company that develops first- or best-in-class targeted medicines for children and adults with life-threatening diseases, with a focus on cancers such as pediatric brain tumors.

BiotechHealthtechSouth San Francisco, US

Jeremy Bender(Executive Officer, Director)

BoardMichael Gladstone(Director)inDerek DiRocco(Director)inJulie Papanek Grant(Director)inJohn Josey(Director)inDaniel Becker(Director)

Board seatJulie Grant· per SEC Form D

Co-investorsAccess BiotechnologyAtlas VentureViking GlobalAccess IndustriesRA CapitalThe Column Group

Dicom GridinMar 2016

Phoenix, US

MORRIS PANNER(Executive Officer, Director)inMICHAEL PALIN(Chief Financial Officer)inGEOFFREY CRAWSHAW(Executive Officer)

BoardSTEPHEN PAPADOPOULOS(Director)JAMES RAMSEY(Director)

Board seatStephen Bloch· per SEC Form D

Dragosdragos.cominOct 2018

Dragos provides cybersecurity software, threat intelligence, and professional services to protect operational technology (OT), IT, and IoT assets in industrial environments.

CybersecurityDefense TechEnterprise SoftwareHanover, US

Robert M. Lee(CEO and co-founder)inJon Lavender(Founder)Justin Cavinee(Founder)

Board seatJoydeep Bhattacharyya· per SEC Form D

Co-investorsAllegisCyber CapitalBYU Cougar CapitalCyber Mentor FundDataTribeEarth FoundryEnergy Foundry+10 more

Eiger BioPharmaceuticalseigerbio.comApr 2011SEC filingmedium confidence

BiotechSanta Clara, US

Jeffrey Glenn(Director)David Cory(Executive Officer, Director)

BoardEd Engleman(Director)

Board seatNina Kjellson· per SEC Form D · $3M raise · filed Apr 2016

Co-investorsPfizer Venture InvestmentsVivo CapitalVivo Ventures

EndoGastric Solutionsendogastricsolutions.com𝕏Apr 2015 · $30M

EndoGastric Solutions offers the Transoral Incisionless Fundoplication (TIF 2.0) procedure and the EsophyX device used to treat GERD, along with reimbursement and technical/administrative support (TAP program) for medical practices.

BiotechHealthtechMedical DevicesSan Mateo, US

Philip Macdonald(Executive Officer)Louis Baldino(Executive Officer, Director)Lilip Lau(Executive Officer)Josh DeFonzo(Executive Officer)in

BoardMichael Carusi(Director)inArda Minocherhomjee(Director)

Board seatBrent Ahrens· per SEC Form D

Co-investorsAccelmed PartnersEvidity Health CapitalLightstone VenturesVCFA GroupAdvanced Technology VenturesDe Novo Ventures+2 more

Envisia Therapeuticsenvisiatherapeutics.cominSeries A · Oct 2015 · $25M

Develops novel ocular therapies.

BiotechMorrisville, US

Ben Yerxa(Executive Officer)inEric Linsley(Executive Officer)in

BoardEd Mathers(Director)inSeth Rudnick(Director)inNeal Fowler(Director)

Board seatStephen Bloch· per SEC Form D

Co-investorsNew Enterprise Associates (NEA)Pappas Capital+ND CapitalARCH Venture PartnersIllumina VenturesOMX Ventures

Even Financialevenfinancial.cominFeb 2017 · $18.8MAcquired

Even Financial, operating as Engine, runs a financial services marketplace and matching network that connects consumers with financial products through APIs and white-labeled experiences.

AI & Machine LearningFintechMarketplacesBrooklyn, US

Phill Rosen(Founder & CEO)Ian Rosen(Executive Officer, Director)Jarid Maged(Executive Officer, Director)

Board seatBrendan Dickinson· per SEC Form D

Co-investorsAAF Management Ltd.Conversion CapitalF-Prime CapitalGreatPoint VenturesMassMutual VenturesValuestream Ventures+6 more

Genome Medicalgenomemedical.comin𝕏May 2018

Genome Medical provides telehealth-enabled genetic services, including genetic counseling, genetic testing, and clinical trial matching, with a focus on individuals with rare conditions.

BiotechDigital HealthHealthtechSouth San Francisco, US

Lisa Alderson(Executive Officer, Director)inRandal Scott(Director)Jill Davies(Executive Officer, Director)inElizabeth Moreno(Executive Officer)inMark Sylvester(Chief Financial Officer)inAndrew Warner(Vice President, Product)in

Board seatStephen Bloch· per SEC Form D

Co-investorsAlumni VenturesAvestria VenturesDreamers VCEcho Health VenturesGV (Google Ventures)Illumina Ventures+11 more

Glookoglooko.comin𝕏Series B · Mar 2021 · $17M

Glooko operates a cloud-connected diabetes management platform that automatically syncs data from CGMs and insulin pumps into care teams' clinical workflows for in-office and remote patient monitoring.

Digital HealthHealthtechSaaSPalo Alto, US

Clay Davidson(Executive Officer)inPrakash Menon(Executive Officer)inEd Marshall(Executive Officer)David Pass(Executive Officer)inAdam Hameed(Executive Officer)inMark Beucler(Executive Officer)in

Board seatWende Hutton· per SEC Form D

Co-investorsHealth Catalyst CapitalRealization Capital PartnersSamsung NextGeorgianMayo Clinic VenturesSocial Capital Partnership

Hyalexhyalex.comin𝕏Series A · May 2017 · $16M

HYALEX Orthopaedics develops a synthetic cartilage platform for joint repair in orthopaedic surgery.

HealthtechMedical DevicesLexington, US

Carl Vause(Executive Officer, Director)inMira Sahney(Executive Officer, Director)inDavid Myung(Director)

BoardMichael Hawkins(Director)William Harrington(Director)in

Board seatWende Hutton· per SEC Form D

Co-investorsOUP (Osage University Partners)Treo Ventures, LlcJohnson & Johnson Innovation – JJDC

JOORjoor.comin𝕏Jun 2021 · $25M

JOOR is a digital wholesale platform connecting brands and retailers globally for buying and selling fashion products.

B2B MarketplacesE-commerceRetail TechSaaSNew York, US

Kristin Savilia(Chief Executive Officer)inMona Bijoor(Founder)

BoardDan Ciporin(Director)inMichael Brown(Director)inEd Neumann(Director)

Board seatMaha Ibrahim· per SEC Form D

Co-investorsAkkadian VenturesBattery VenturesEastward Capital PartnersGreat Oaks Venture CapitalMultiplier CapitalBrightwood Capital Advisors+3 more

Journey Livejourney.liveinSeed · Apr 2025 · $2M

Journey is an Employee Assistance Program (EAP) that combines predictive analytics, personalized outreach, and a clinical network — powered by its Journey Signal AI engine — to detect employee mental health risk early and provide proactive care.

AI & Machine LearningEnterprise SoftwareHR TechMental HealthNew York, US

Stephen Sokoler(Founder & CEO)inSue Zbikowski(Chief Clinical Officer)in

BoardJoshua Siegel(Director)

Board seatBrendan Dickinson· per SEC Form D

Co-investors37 AngelsAlumni VenturesBetaworksCity LightCourtside VenturesHealthtech Capital+10 more

Komprisekomprise.comin𝕏Series A · Apr 2015 · $6M

Komprise provides analytics-driven unstructured data management and mobility software that helps enterprises analyze, tier, and move file and object data across storage systems and the cloud, including curating data for AI.

AI & Machine LearningCloud ComputingData & InfrastructureEnterprise SoftwareCampbell, US

Krishna Subramanian(Founder)inKumar Goswami(Executive Officer, Director, Promoter)inMike Peercy(Founder)inKumar K. Goswami(Founder)Michael Peercy(Founder)

Board seatMaha Ibrahim· per SEC Form D

Co-investorsCelesta CapitalMultiplier CapitalWestern Digital CapitalTop Tier Capital PartnersWalden International

Kustomerkustomer.comin𝕏Series A · Nov 2019 · $10M

Kustomer is an AI-native customer experience (CX) platform that ties every interaction to a complete customer record so AI and human agents can respond with full context, automate conversations, and manage support workflows.

AI & Machine LearningEnterprise SoftwareSaaSSales TechShort Hills, US

Jeremy Suriel(Founder)inBrad Birnbaum(Founder)inMichael Chapin(Executive Officer, Promoter)

BoardScott Beechuk(Director)inAlex Bard(Director)inNeeraj Agrawal(Director)in

Board seatDeepak Kamra· per SEC Form D

Co-investorsAcurio VenturesBattery Venturesboldstart venturesBoxGroupCisco InvestmentsCoatue Management+8 more

Myndmynd.coin𝕏May 2018 · $20M

Mynd offers full-service property management for single-family rental investors, handling tenant placement, leasing, maintenance, and communications, with a tech-based investor portal for real-time portfolio visibility.

Enterprise SoftwareFintechPropTechSaaSOakland, US

Colin Wiel(Founder)inDoug Brien(Founder)in

Board seatRichard Boyle· per SEC Form D

Co-investorsAssurant VenturesJackson Square VenturesLightspeed Venture PartnersQED InvestorsR136 VenturesThirdstream Partners+2 more

nTopologyntop.comin𝕏Jun 2020 · $65M

nTop provides a software platform for engineering design that uses implicit modeling and physics-based simulation to accelerate product development.

Advanced ManufacturingAI & Machine LearningDeep TechDeveloper ToolsEnterprise SoftwareSaaSNYC, US

Gregory Schroy(Executive Officer, Director, Promoter)Bradley Rothenberg(Founder)in

Board seatHrach Simonian· per SEC Form D

Co-investorsIn-Q-TelNimble PartnersNotation CapitalPathbreaker VenturesRoot Ventures Manager, LlcTuesday Capital+7 more

Olliemyollie.comMar 2024acquired by Agrolimen

Ollie provides personalized fresh dog food recipes crafted by chefs and food scientists, paired with health monitoring services that analyze dog wellness indicators to optimize nutrition and health outcomes for pet owners.

ConsumerFoodTechNew York, US

Nick StaffordinDan Ciporin(Director)Alexandre Douzet(Executive Officer, Director)Steve Marton(Director)

BoardBenjamin Sun(Director)in

Board seatLaura Chau· per SEC Form D

Co-investorsAlumni VenturesARC Angel FundCorrelation VenturesDarco CapitalFelicis VenturesInterplay Ventures Early Stage Management Llc+6 more

OncoResponseoncoresponseinc.comSeries A · Apr 2025 · $14M

Clinical-stage immuno-oncology company developing antibodies derived from the immune systems of 'Elite' cancer responders.

BiotechHouston, US

Alice Bexon(Executive Officer)inClifford J. Stocks(Director, Executive Officer)inKamal D. Puri(Executive Officer)inChris Russell(Executive Officer)inRuss Hawkinson(Executive Officer)

BoardSteven Gillis(Director)in

Board seatWende Hutton· per SEC Form D

Co-investors3B Future Health FundGreatPoint VenturesRiverVest Venture PartnersAlexandriaARCH Venture PartnersBering Capital+5 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Annum HealthButterfly HealthClutch Technologies Inc.Confetti CollectiveFast LabsLyceraMinimally Invasive DevicesMosey WorksMschf Product Studio IncNexcida TherapeuticsNotable FinanceOneLookReischling PressRevision OpticsStargazer PharmaceuticalsTheraclone SciencesVitruvian NetworksAdvanced BioHealingAlsius CorporationAlterEgo NetworksAltheosAmicasApieronAppliedArbor NetworksArgon NetworksAssociated ContentAtheroMedAxcelius I/IIBenefit SolutionsCalibra MedicalCalixa TherapeuticsCAPMAC HoldingsCapstone Turbine CorporationCell PathwaysCellular ResearchCerexaClimacellCloud CaptainCode Green NetworksCombinatoRxCommerce OneConcord CommunicationsCopper Mountain NetworkCortina SystemsCrossLogix

Browse all 501 investments with full details →

▶301 more tracked companies

CytomX Therapeutics HoldingsData Sciences InternationalDauntless PharmaceuticalsDermiraDexterraDiffusion SoftwareDiligent RoboticsDomu Technology Inc.DoorStepDoubleClickDrivetimeDurata TherapeuticsDusty RoboticsEarnipayeBatesEchopassEdge ImpulseElevation PharmaceuticalsEmbrokerEmissaryEmissaryEngine by MoneyLionEnpirionEnterpretEon LaboratoriesEphemeralEsperion TherapeuticseStampEternalEverdream CorporationExecthreadExecThread, Inc.Field AIFireflies AiFLA HoldingsForteFrame TechnologyGen.GGenome Medical, Inc.GenVecGigyaGojunoGoodwin CompanyGrey Wolf TherapeuticsGrokStyleGroundWork Open SourceHabeasHalda TherapeuticsHeliumHereHermeusHermeus Mach 5 engineHeyMiloHighriseHighriseHomeisHugoHuman SecurityID AnalyticsIllumicellImanis DataImmunicon CorporationInstante SoftwareInstrumentalInteleradIntelliCareInteract CommerceInternational Network ServicesIntralinksIntrawareIntrepida BioIntrepidiaBioiPrint TechnologiesIstante SoftwareItalicItalicIterumIterum TherapeuticsJinaJobDirectJoinJoinJoin DigitalJOORJourney MeditationJumpcutJumpcutJunoKabamKalpanaKeplerKepler CommunicationsKickpayKin EuphoricsKinecta CorporationLabrys BiologicsLadderLancopeLatitude CommunicationsLeanplumLeap To Win Technologies Private LimitedLendingClubLevLily AILiveUlobby-pastinv-ebates@2xMachEyeMani.MeMantraMantraMariner Health GroupMarinus PharmaceuticalsMarvinMarvinMateMate SecurityMatrimony ComMatrix PharmaceuticalMC SciencesMetacloudMiggosMightyTVMindTickleMiraMirarealityMobilitecMoCaFiMoseyMoseyMoviePassMSCHFNaaptolNagishNanoGramNatureBoxNeoPhotonics CorporationNETSCOUTNetwork EnginesNivoda LimitedNocionNodeNodeNormunityNorthstar NeuroscienceNova LabsNoveeNoveeNovee SecurityNovira TherapeuticsOllieOn DeckON24OncolineaOncoLinea PharmaceuticalsOncologyOnDeck (nZero)Ondeck CapitalOnDemandOnefinestayOnePipeOneSource ServicesONI Systems CorporationOnramp Payments, Inc.OpenArtOpenSkyOrapharma IncOrchardOrchard (formerly Perch)Orthocon, Inc.PAGE TechnologiesPapaPartifulPathios TherapeuticsPaxosPeer39Peninsula PharmaceuticalsPlayers' LoungePlixiPocket WorldsPodzPozenPraecis PharmaceuticalsPrax HealthPremier Laboratory ServicesPrimeSenseProperty CapsulePropicoProvenance Technologies, Inc.Quarry TheraRADD PharmaceuticalsRally Network, Inc.RamReRapidataReactive BioReactive BiosciencesReflex Careers, Inc.ReibusReibus LogisticsReplicantRepoolRevivantRightPointRoRoRocketripRondo TherapeuticsRoofstockRyloSafireSageOxSample6SavvySavvyScaleFactorSemnur PharmaceuticalsSensageShara Inc.ShopKeepSIDSidechatSilicon OptixSilverRailSilverRail TechnologiesSitterSkale LabsSkybox ImagingSmack TechnologiesSnooth MediaSnykSolvelySpecific LabsSpectrianSpinifex PharmaceuticalsStayfulStratosphereSuccessFactorsSuiza FoodsSumbleSuperplasticSuperplastic Synthetic SuperstarsSureWavesSwitchflySynthekineTacit NetworksTAGTallanTariTelariaTelitTerrasoftTerretThe InsideThe MetaTiaTiaTobira TherapeuticsTomorrow IoTrébolTremorTriton Therapeutics, Inc.TropicTropic BiosciencesTrotana TherapeuticsTrueFortTubular LabsTubular Video analytics platformTuroTwenty20TyraUncommonUnifiUniform TeethURoamValidVaxinnateVedana Therapeutics, Inc.VersableVictoriousVima Therapeutics, Inc.VinetiVirsto SoftwareVirtuoso Therapeutics, Inc.Visigenic SoftwareVisipriseVoyenceVue TechnologyWebloyaltyWelltokWise LayerwithcoWizRocket, Inc. (d/b/a CleverTap)WonderhillWorkmotionWorld ViewWoveXirrusZANDIVIO LTD (d/b/a Uniform Teeth)ZiploopZmandaZooskZugata

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Exits · 126

21 IPOs · 105 acquisitions · showing 42

Arvinas Holding Co. LLCNASDAQ: ARVNCardlyticsNASDAQ: CDLXCytomX TherapeuticsNASDAQ: CTMXLiquidia CorporationNASDAQ: LQDALiquidia TechnologiesNASDAQ: LQDANextCureNASDAQ: NXTCRallybio HoldingsNASDAQ: RLYBTYRA BiosciencesNASDAQ: TYRAAevaNASDAQ: AEVAArbeNASDAQ: ARBECiscoNASDAQ: CSCODexComNASDAQ: DXCMGinkgo BioworksNYSE: DNAIdeaya BiosciencesNASDAQ: IDYAInstacartNASDAQ: CARTLightspeedNYSE: LSPDLiveRampNYSE: RAMPMatchNASDAQ: MTCHProtagonist TherapeuticsNASDAQ: PTGXRallybio, LLCNASDAQ: RLYBSandforceNASDAQ: STXOllieacq. by AgrolimenAdvanced BioHealingacq. by ShireAim Securityacq. by Cato NetworksAlsius Corporationacq. by ZOLL Medical CorporationApieronacq. by AerocrineArbor Networksacq. by NetScout SystemsArgon Networksacq. by SiemensAssociated Contentacq. by YahooAtheroMedacq. by Volcano CorporationBeckonacq. by IgniteTechCalibra Medicalacq. by Johnson & JohnsonCalixa Therapeuticsacq. by Cubist Pharmaceuticals, Inc.CAPMAC Holdingsacq. by MBIA Inc.Cell Pathwaysacq. by OSI Pharmaceuticals, Inc.Cellular Researchacq. by Becton, Dickinson and Company (BD)Cerexaacq. by Forest LaboratoriesCombinatoRxacq. by Horizon Discovery Group plcConcord Communicationsacq. by Computer Associates (CA)Copper Mountain Networkacq. by Tut SystemsCortina Systemsacq. by InphiCrossLogixacq. by BEA Systems, Inc.

Portfolio news

latest coverage across their companies

Fund performance · per public LP disclosures · 9

as of Jun 2025
FundVintageCommittedNet IRRTVPIDPI
Canaan XIII Healthcare Fund L.P.LPs: California Public Employees' Retirement System2024——0.59x0.00x
Canaan XIII L.P.LPs: California Public Employees' Retirement System2024——0.90x0.01x
Canaan Gold Coast L.P.LPs: California Public Employees' Retirement System2023——1.03x0.00x
Canaan XII L.P.LPs: Los Angeles County Employees Retirement Association2020—3.4%1.10x0.00x
Canaan XI, L.P.LPs: Los Angeles County Employees Retirement Association2017—9.7%1.68x0.06x
Canaan IXLPs: The Regents of the University of California, Hawaii Employees' Retirement System2012—19.1%2.04x0.93x
Canaan VIII, L.P.LPs: The Regents of the University of California, Hawaii Employees' Retirement System2007—8.9%1.44x1.24x
Canaan Equity Partners VIILPs: The Regents of the University of California2005—16.0%2.44x1.50x
Canaan VII, L.P.LPs: The Regents of the University of California, Los Angeles County Employees Retirement Association, Hawaii Employees' Retirement System2005—14.6%2.53x2.33x

Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).

IPO stake values · per SEC filings · 7

Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.

CompanyOwnedIPO priceAt IPOStake value
NextCure8.4%$36.75Nov 2019$82.9M
TYRA Biosciences10.8%$16.00Sep 2021$70.6M
CytomX Therapeutics14.0%$12.00Oct 2015$58.6M
Rallybio, LLC7.5%$13.00Jul 2021$30.3M
Rallybio Holdings7.5%$13.00Jul 2021$30.3M
Protagonist Therapeutics14.9%$12.00Aug 2016$29.4M
Ideaya Biosciences11.6%$10.00May 2019$22.6M

Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).

Frequently asked questions

How many investments has Canaan Partners made?
Canaan Partners has 501 tracked investments, 126 of which have exited, including 39 dated in the last 24 months.
What stage does Canaan Partners invest at?
Canaan Partners invests at the Pre-Seed, Seed, Series A stages.
What is Canaan Partners's typical check size?
Canaan Partners typically writes checks of $500K – $20M.
What sectors does Canaan Partners focus on?
Canaan Partners focuses on Biotech, Cloud Computing, Consumer, Deep Tech, Digital Health, E-commerce, Enterprise Software, Fintech, Gaming, Healthtech, Medical Devices.
Where is Canaan Partners located?
Canaan Partners is headquartered in Stamford, US.
Does Canaan Partners lead rounds?
Yes, Canaan Partners leads investment rounds.
Who does Canaan Partners co-invest with?
Canaan Partners most often shares deals with Alumni Ventures, FJ Labs, Y Combinator, among 787 tracked co-investors.

Media · Podcasts & interviews

featuring the team

Zuckerberg's Puerto Rico VR video was in poor taste but uncharacteristic for him: Canaan Partners' Maha Ibrahim

Maha Ibrahim · cnbc.com

Wende Hutton, Canaan Partners

Life Science Washington · Wende Hutton

Deepak Kamra, Canaan Partners: Innovation

Tech4Obama · Deepak Kamra

Deepak Kamra, Canaan Partners: Keys to Success

Tech4Obama · Deepak Kamra

Deepak Kamra, Canaan Partners: Lessons Learned

Tech4Obama · Deepak Kamra

Deepak Kamra, Canaan Partners: Rapid Fire Questions

Tech4Obama · Deepak Kamra

Images

Canaan Partners photoCanaan Partners photoCanaan Partners photoCanaan Partners photoCanaan Partners photoCanaan Partners photoX profile banner

Co-investors · 265

Alumni Ventures

Alumni Ventures (AV) is a venture capital firm that co-invests alongside lead VCs in startups, backing founders with capital and access to a large investor and operator community.

$100K – $10M
GV (Google Ventures)

GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.

$250K – $50M
General Catalyst

General Catalyst is a venture capital firm operating as a partnership focused on company building and accelerating the growth of the businesses it backs.

$30M
Khosla Ventures

Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.

$100K – $20M
New Enterprise Associates (NEA)

New Enterprise Associates (NEA) is a venture capital firm that invests in and provides long-term support to founders building new companies.

$200K – $40M
Insight Partners

Insight Partners is an investment firm focused on accelerating revenue and profit growth in software companies, providing capital and operational support through its Insight Onsite team.

$120M – $350M
FJ Labs

FJ Labs is an early-stage investment firm specializing in marketplaces and network-effect businesses, taking an angel-style co-investment approach alongside institutional venture funds worldwide.

$100K – $3M
Lightspeed Venture Partners

Lightspeed Venture Partners is a global venture capital firm that backs founders from Seed through Series F and beyond, emphasizing deep, immersive partnerships with the companies it invests in.

$1M – $5M
BoxGroup

BoxGroup is an early-stage venture capital firm that invests in startups at their earliest stages.

$250K – $1M
RA Capital

RA Capital Management is a healthcare and planetary health investment firm that founds, funds, and scales companies using scientific diligence, multi-stage capital, and hands-on operational support.

Bessemer Venture Partners

Bessemer Venture Partners is a global venture capital firm that partners with entrepreneurs across enterprise, consumer, and healthcare sectors from early stages through growth.

$50K – $100M
Accel

Accel is a venture capital firm that partners with exceptional teams, positioning itself as a first partner to founders globally.

$500K – $100M
▶253 more co-investors

Comcast Ventures5AM VenturesConnecticut InnovationsAndreessen HorowitzIndex VenturesRedpoint VenturesFelicis VenturesKleiner PerkinsCoatue ManagementNorwest Venture PartnersRRE VenturesSoftBank Vision FundAugust CapitalARCH Venture PartnersCorrelation VenturesOUP (Osage University Partners)In-Q-TelSpark CapitalBattery VenturesACME CapitalF-Prime CapitalCostanoa VenturesOrbiMedSofinnova VenturesLightstone VenturesFirst Round CapitalFoundation CapitalDCVC (Data Collective)Great Oaks Venture CapitalFirstMark CapitalUS Venture Partners500 GlobalShasta VenturesCiti VenturesNyca PartnersGE VenturesNextech InvestNew Leaf Venture PartnersSequoia CapitalSound VenturesCRV (Charles River Ventures)HeadlineScale Venture PartnersCota CapitalSierra VenturesIntel CapitalTribe CapitalDreamers VCTorch CapitalZeev VenturesJohnson & Johnson Innovation – JJDCDomain AssociatesConductive VenturesNovo HoldingsCasdin CapitalSapphire VenturesOffline VenturesLiquid VenturesGreycroftForerunner VenturesAcrew CapitalRevolutionAtlas VentureSocial LeverageWinklevoss CapitalInspired CapitalTribeca Venture PartnersWebb Investment NetworkCisco InvestmentsNewView CapitalNext Coast VenturesFlare Capital PartnersRoot Ventures Manager, LlcMassMutual VenturesThird Rock VenturesAdvance Venture PartnersAlta PartnersHealthQuest CapitalBase Venture Management, Inc.Thompson Hutton, LLCAvoro Capital AdvisorsKaiser Permanente VenturesLong Journey VenturesFounder CollectiveNotable CapitalBenchmarkPlug and Play VenturesMayfield FundFundersClubAME Cloud VenturesFifth WallPrecursor VenturesAdditionPICUS CAPITALCrosslink CapitalVenrockDN Capital75 & SunnyCyberstartsFuel Capitalboldstart venturesPelion Venture PartnersDnx VenturesAmerican Express Ventures (Amex)Tusk Venture PartnersMango CapitalStorm VenturesXYZ Venture CapitalHouseVertex Ventures Sea Management Pte. Ltd.National Grid PartnersSquare Peg CapitalFontinalis PartnersSR One Capital ManagementWalden CatalystDeerfield Management CompanyTola CapitalvenBio PartnersThe Column GroupPivotal Life SciencesMorgenthalerBlueYard CapitalAccess IndustriesHatteras Venture PartnersAdvent Life SciencesVida VenturesPontifax Venture CapitalBrandProject CapitalRed Tree VentureCraft VenturesUncork CapitalTrue VenturesQuiet CapitalPartech VenturesSciFi VCEmergence Capital PartnersBowery CapitalBonfire VenturesTrinity VenturesTrajectory VenturesNext47Polaris PartnersParadigmBase10 PartnersBlockchain CapitalPrimary Venture PartnersAngelPadBetter Tomorrow VenturesRenegade PartnersBallistic VenturesDigital Currency GroupBaseline VenturesZetta Venture PartnersEnergy Impact PartnersAcequia Capital (AceCap)Flourish VenturesWork-BenchNGP CapitalMischiefOrigin VenturesPitangoTen ElevenEQT Life SciencesWestWave CapitalSutter Hill VenturesJAZZ Venture PartnersPaladin Capital GroupMiramar Venture PartnersIndicator VenturesSofinnova PartnersVersant VenturesGrotech VenturesSpace CapitalMithril Capital ManagementXAngeAbingworthStanford UniversityClearvision VenturesTwo Bear CapitalFrazier Healthcare PartnersGlencrest GroupOne Planet GroupTop Tier Capital PartnersAnkona CapitalDolby Family VenturesMTECH CAPITALRiverVest Venture PartnersMomenta VenturesIA Capital Group125 VenturesStarVest PartnersVensana CapitalVertical Venture PartnersWestlake Village BioPartnersJMI EquityOkapi Venture CapitalRET VenturesAdjuvant CapitalAvedro, Inc.Emerson Collective InvestingGreylock PartnersHCVCObvious VenturesResolute VenturesGeneral PartnershipChemistryEclipse VenturesOperator Collective8-Bit CapitalWildcat Venture PartnersCompany CapitalXtripe AngelsThe Finger GroupZ47S28 CapitalRavelin CapitalRubicon Venture CapitalG2 Venture PartnersParade VenturesArtis VenturesAngular VenturesAZ-VCS32AI FundSpace Tech VenturesEpisode1Illuminate VenturesNazcaHelion Venture PartnersRedpoint eventuresKOMPAS VCANIMO VenturesAutotech VenturesXSeed CapitalAsset Management VenturesAcrobator VenturesNorthside VenturesPritzker Group Venture CapitalSmartStart FundOmega FundsTunitas VenturesJefferiesNorthwestern Mutual Acceleratoralpha4 venturesALLVPMerian VenturesStaircase VenturesGoldcrest CapitalD.E. ShawStartup Capital VenturesPappas CapitalUnion Square Advisors LLCBioInnovation Capital

Firms observed investing alongside Canaan Partners, from public investor directories. Shared companies are the overlap with Canaan Partners's recorded portfolio.

Similar investors

Featured in lists